Introduction
Idiopathic pulmonary arterial hypertension (PAH) is a rare but fatal disease with a survival rate of 58% in 3 years. 1 Present therapy is unable to normalize pulmonary arterial pressures and PAH-patients ultimately develop right heart failure. 2 Previous studies have demonstrated that PAH-patients have reduced systolic function as measured by RV ejection fraction. However, the knowledge on the role of RV diastolic stiffness in PAH is limited. Measuring RV diastolic stiffness has been hindered until now, because noninvasive techniques (echocardiography, magnetic resonance imaging) provide only information on relaxation velocities and not on diastolic stiffness per se. 3 In addition, these measures are highly sensitive to the confounding effects of increased pre-and afterload, and are therefore not reliable in the setting of PAH. 4 On the other hand, the gold standard of measuring loadindependent diastolic stiffness by pressure-volume (PV) analysis is not without risk in PAHpatients, since it requires temporal preload reduction. 3 In left heart failure this was circumvented by the development of single-beat analyses of diastolic PV relationship. 5, 6 However, it is unclear whether this analysis could also be used for the right ventricle in PAH.
There are several possible contributing factors explaining RV diastolic stiffness in PAH.
Hypertrophy and fibrosis are known to increase ventricular stiffness. 7 But RV diastolic stiffness could also be caused by changes in the contractile apparatus of RV cardiomyocytes: the sarcomeres. Sarcomeric stiffness is tightly regulated by the giant sarcomeric protein titin. 8 Titin consists of two isoforms: the stiff N2B isoform and the compliant N2BA isoform. Besides changes in isoform composition, titin compliance is regulated by phosphorylation. Whether these factors are altered in human PAH pathophysiology is unknown.
Therefore, the aim of this study is to determine the presence of RV diastolic stiffness in highly sensitive to the confounding effects of increased pre-and afterload, and a ar r re t t the here refo fo fore re re n no ot f f eliable in the setting of PAH. 4 On the other hand, the gold standard of measuring loadn nde de epe pe pend nd nden en ent t
t d d dias as sto to toli lic stiffness by pressure-volum m me ( (PV) analysis s i i is no ot t t w w without risk in PAH-
pati i ien e ts, since e it i it re e equi ui uire res s s te te temp mp mpor oral al al p p pre relo loa ad r red d duct ti io on n. 3 I In n n le le eft t h hea ea art t t f fai ai ilu lu lur re e th th his is is w was as as c c cir irc c cum mv mve en ent t ted PAH-patients and explore the contribution of collagen formation, sarcomeric stiffening and posttranslational modifications of titin in RV tissue of PAH-patients.
Methods

Assessment of RV diastolic stiffness
Hemodynamic data was obtained from digitally stored routine clinical measurements. Patients Solutions, Erlangen, Germany). During right heart catheterization, radial or femoral blood samples were collected and standard laboratory tests including N-terminal pro-brain natriuretic peptide level (NT-proBNP) were performed. 9 New York Heart Association (NYHA) class and six-minute-walk-distance (6MWD) were registered during the same clinical evaluation. All patients were evaluated in stable hemodynamic condition, lying supinely and breathing at normal frequencies. 2 Patients were selected based on the following criteria: good-quality recordings of right heart catheterization pressure curves with cardiac MRI performed within the same hospital admission and under the same hemodynamic condition (n=28). PAH was diagnosed according to the PAH diagnostic guidelines (n=21). 10 Controls were selected from referred patients suspected with PAH but in whom the condition was ruled out after recording normal pulmonary pressures during right heart catheterization (n=7).
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Right heart catheterization
The following invasive variables were recorded: right atrial pressure (RAP), RV pressure, mean pulmonary artery pressure (mPAP) and pulmonary capillary wedge pressure (PCWP). Cardiac output (CO) was determined by Fick method and pulmonary vascular resistance (PVR) was calculated using PVR=(mPAP-PCWP)/CO. 11 Diastolic filling pressures were measured at minimum pressure point (recorded after tricuspid valve opening) and noted as begin-diastolic pressure (BDP). End-diastolic pressure (EDP) was recorded at maximal diastolic filling pressure point before the onset of isovolumic contraction (Fig. 1A) .
Cardiac MRI
RV volumes were calculated using Mass software (MEDIS, Medical Imaging Systems, Leiden, the Netherlands) from multiple short axial-slice MRI analysis. 2 End-systolic volumes (ESV)
were considered to correspond to BDP and is further referred as begin-diastolic volumes (BDV), while end-diastolic volumes (EDV) corresponded to EDP (Fig. 1A) . Stroke volume was calculated from MRI-derived pulmonary artery flow and used to accurately determine RV BDV.
RV volumetric filling curves were obtained from the stack of short-axis cine images for the quantification of RV early (E) and atrium (A) induced peak filling rate (E/A ratio) as previously described.
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Single-beat pressure-volume analysis PV relations were constructed by fitting a non-linear exponential curve through the diastolic PV points using the following formula:
P= (e V -1) (Equation 1), 5, 6 where P: pressure; : curve-fitting constant; : diastolic stiffness constant; V: volume.
RV volumes were calculated using Mass software (MEDIS, Medical Imaging Sy ys ste te em ms s, , Le Le Leid id iden en, , he Netherlands) from multiple short axial-slice MRI analysis. 2 End-systolic volumes (ESV)
we were re re c c co on onsi si side de der red d to to to c correspond to BDP and is fu urt rt rthe he er referred as be be b gin-n--di di dias a tolic volumes (BDV), RV volumetri ri ic c c fi fi f ll ll llin in ing g g cu cu urv v ves es es w wer er ere e e ob ob obta a ain in ined ed ed f f fro ro rom m m th th he e e st stac ac ack k k of of o s s sho ho hort t t-a -a -axi xi x s s s ci ci c ne ne n i i ima ma mage ge ges s fo f r the
The slope of the curve was characterized by the exponential term and the curve constant , which were further used to quantify RV diastolic stiffness. The first two points used to construct the PV relation were the BDP-BDV point and the EDP-EDV point. The third PV point used to construct the diastolic PV relation was set at 0 pressure ,0 volume , since prolonging the PV curves to volumes lower than the intercept volume does not modify the exponential term and the curve constant (see supplemental data). Due to large variation in EDV in control patients compared to PAH-patients, the EDV was normalized to the maximal EDV recorded among the patients. Consecutively, the BDV was calculated by subtracting the corresponding stroke volume from the normalized EDV. To avoid measurement errors due to the positioning of the RV catheter, BDP was normalized at 1mmHg, while the EDP was calculated with the following formula: EDP normalized =1+(EDP initial -BDP initial ). To account for covariance in and , derived and of each individual subject were used to calculate the V at a common P of 20mmHg (V 20 ).
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Experimental support for the use of single-beat instead of multiple-beat RV diastolic PV relation was obtained in rats with PAH-induced right heart failure undergoing right heart catheterization with a conductance catheter and echocardiography. For details see the online supplement.
Assessment of RV end-systolic elastance
The slope of the end-systolic pressure volume relation (end-systolic elastance, Ees) was calculated as previously described: Ees = (P iso -mPAP)/SV. 13 The isovolumic pressure (P iso ) was obtained by fitting an inverted cosine wave over the RV pressure curve using the isovolumic contraction period (from end-diastole to the point of maximal rate of pressure rise (dP/dt max )) and the isovolumic relaxation period (from minimal dP/dt to start diastole) by a semi-automatic he RV catheter, BDP was normalized at 1mmHg, while the EDP was calculated d w wit it i h h th th the e e following formula: EDP normalized =1+(EDP initial -BDP initial ). To account for covariance in and , de eri ri ive ve ved d d a a and nd nd o o of f f ea e ch individual subject were u u use sed to calculate t t the h V V V a a at t a common P of 2 20 0m mm mmHg (V 20 0 ) ).
Matlab R2008a program (The MathWorks, Natick, MA).
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RV histological analyses.
Explanted RV tissue samples were collected from PAH-patients undergoing heart/lung transplantation (n=10). Control RV tissue was obtained from non-failing donors (n=9). Written informed consent was obtained and the study protocol was approved by the local ethics committees. All samples were immediately frozen and stored in liquid nitrogen. 
RV cardiomyocyte force measurements
Tissue pieces were defrosted in relaxing solution and single cardiac cells were isolated mechanically as described before (7 control and 7 PAH samples). 19 A minimum of 3 cells per sample were measured and the average total, active and passive tension were calculated.
Cardiomyocytes were incubated for 5 minutes in relaxing solution containing 1% Triton X-100 non-transversal cross-sections were not included in the analysis. [15] [16] [17] [18] RV fibrosis was determined on 5 m-thick tissue sections stained with picrosirius red and an nal al alyz yz yzed ed ed u u und nd nde er d d dou ou oubl b e-polarized light. 16, 17 Image ge ges s w w were collected d b by th th he e e us u e of a Leica DMRB m mic cr croscope (We We W tz tzla lar, r, G Ger er erma ma many n ny), ), a a a S S So on ny y y XC C C-7 7 77C CE E came me m ra ra (T To Tow wa wada da, J Ja J p pa pan) n) n) a a and nd a a a L L LG-G-G-3 fr fr fram am me e e gr grab ab abbe be ber r (S (S (Sci ci cio ] at which 50% of maximal force was obtained. Steady-state F passive measurements were performed at increasing sarcomere lengths (1.8 -2.6μm).
To determine tension, we corrected for differences in RV cross-sectional area between control and PAH. Individual force values were normalized for the cardiomyocyte width and depth recorded at 2.2μm sarcomere length.
Contribution of actomyosin interaction to passive tension was determined by incubating skinned cardiomyocytes with actomyosin inhibitor 2,3-butanedione monoxime (BDM; 25mM) at 15°C, for 10 minutes. 21 After 10 minutes active tension was measured in maximal activation solution to determine the efficiency of the compound. Subsequently, passive tension was recorded at increasing sarcomere lengths (1.8 -2.4μm) and compared to passive tension recorded before BDM incubation.
Titin isoform composition and phosphorylation
Frozen RV tissue samples were weighed and pulverized in liquid nitrogen using a mortar and To det ter ermi mi mine e t t ten n nsi si sion on on, w we we c c co or orre re ect ted f f for r r dif f ffe e erenc nc nces es i i in RV RV V c c cro oss ss-s se ect ctio io iona nal l a a are ea ea b b bet t tw we ween en en co ont nt n ro ro ol l l an and d products and MHC were quantified and Titin N2B/N2BA ratio was determined.
To quantify titin phosphorylation, gels were stained for 2 hours with ProQ diamond (Molecular Probes). Thereafter, the gels were washed and subsequently stained with SYPRO Ruby (Molecular Probes).
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Statistical analyses
Statistical analyses were performed using Prism 5 for Windows (GraphPad Software Inc, San Diego, CA). Normal distribution was tested and logarithm transformation was performed if necessary. P-values lower than 0.05 were considered significant.
Changes in patient characteristics and diastolic stiffness were tested for significance with unpaired Student t-tests or non-parametric Mann-Withney U test (RAP, NT-proBNP). The relation between diastolic stiffness and several variables for disease severity (SV, 6MWD, RAP and NT-proBNP levels) was tested with Pearson's correlation. To adjust for possible confounding by body surface area, age, treatment duration and pulmonary vascular resistance, multivariable regression analyses was performed. Histological data were analyzed using multilevel analysis to correct for non-independence of successive measurements per patient (MLwiN 2.02.03, Center for Multilevel Modeling, Bristol, UK). [15] [16] [17] [18] 23 Changes in cardiomyocyte maximal tension, Ca
2+
-sensitivity and passive stiffness were tested for significance by repeated Ruby (Molecular Probes).
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Statistical analyses
St tat at tis is isti ti tic ca cal l l an an a a a alys ys ses es es w were performed using Prism m m Chan nge ge ges s s in in n p p pat at tie ie ent t c c cha ha hara a act ct cter er ris is i ti i ics cs c a a and nd nd d d dia ia iast st stol ol lic ic st st stif if iffn fn fnes es ess s s we we were re re t t tes es este te ted d d fo fo or r r si si s gn gn gnif if ific i ance with h h measures ANOVA followed by Bonferroni post-hoc test.
Results
Assessment of RV diastolic stiffness
RV diastolic stiffness was calculated in PAH-patients (n=21) and controls (n=7). The clinical characteristics of the patients enrolled in this part of the study are described in Table 1 As can be observed in the online supplement, multiple-beat ( multiple ) and single-beat ( single ) derived RV diastolic stiffness were closely correlated in rats (R 2 =0.94; p<0.001).
Therefore, we used the single-beat method to calculate RV diastolic stiffness in PAH-patients and controls. The average PAH and control diastolic curves are presented in Fig. 1B . Compared to the control curve, the steeper PAH-curve indicates increased stiffness of the myocardium. On average, PAH-patients had an almost two-fold increase in RV diastolic stiffness parameter (Fig. 1C) , and a reduced curve constant ( Table 2) . After controlling for the covariance of and , RV diastolic stiffness remained significant in PAH-patients in comparison to control (V 20 ; Table 2 ). Non-invasive assessment of diastolic dysfunction by measures of MRI-obtained E/A ratio confirmed the observed increase in RV diastolic stiffness in PAH-patients (Fig. 1D) . In ignificantly higher in PAH-patients compared to controls. Furthermore, RV ejec ec cti tion o o f f fra ra ract ct ctio io ion n was lower in PAH-patients, as well as CO. PAH-patients were in a relatively good functional To investigate whether RV diastolic stiffness is also present in other forms of pulmonary hypertension, we included an additional group of patients with chronic thrombo-embolic pulmonary hypertension (CTEPH; n=24 RV diastolic stiffness, characterized by the curve constant , significantly correlated with PAH disease severity. Stroke volume and 6MWD were significantly and inversely correlated with RV diastolic stiffness, suggesting that increased RV cardiomyocyte stiffness is associated with reduced cardiac function and exercise capacity ( Fig. 2A,B) . In addition, RV diastolic stiffness was closely correlated to RAP and NT-proBNP, both markers of increased RV stiffness and wall stress (Fig. 2C,D) . These correlations remained significant after correction for the possible confounding effects of age, gender, body surface area, treatment duration and PVR (Table 3) .
RV histology analyses
To perform histological analyses, RV tissue samples were obtained from PAH-patients (n=10) and controls (n=9). Patient characteristics are shown in Table 4 . A two-fold increase of RV cardiomyocyte cross-sectional area in PAH was found compared to control cardiomyocytes (PAH: 531±34 μm 2 vs. control: 256±24 μm 2 , p<0.001; Fig.3A) . In addition, a significant increase in collagen content was found in PAH tissue sections compared with controls (PAH:
9.6±0.7% vs. control: 7.2±0.6% p<0.01; Fig.3B ).
PAH disease severity. Stroke volume and 6MWD were significantly and inversel el ly y co c c rr rr rrel el elat at ated ed ed with RV diastolic stiffness, suggesting that increased RV cardiomyocyte stiffness is associated wi with th h r r red ed educ uc ced ed ed car ar rdi di dia ac function and exercise capa a ac ci city y y ( Fig. 2A,B) . I I In n ad d ddi di diti tion, RV diastolic
RV cardiomyocyte force measurements
To investigate the contribution of sarcomeric stiffening on RV diastolic stiffness in PAH, we isolated and membrane-permeabilized single RV cardiomyocytes of RV tissue from PAHpatients (n=7) and controls (n=7). -sensitivity were observed between PAH and controls, although the averaged tension-calcium curve was slightly shifted to the left in PAH (Fig. 4C) . Overall, RV cardiomyocytes in PAH had a significantly higher total tension compared to control cardiomyocytes over a broad range of calcium concentrations (Fig.4D ).
Second, we determined cardiomyocyte passive tension (measure of sarcomeric stiffness)
in relaxing solution at increasing sarcomere lengths (1.8 to 2.6 μm). A significantly higher cardiomyocyte passive tension at different sarcomere lengths was observed in PAH compared to control cardiomyocytes (+200%; Fig.5A ). The relative increase in passive tension observed in PAH-patients compared to control cardiomyocytes at both 1.8 a m m nd 2.2μm, althou u ugh gh gh t the he he difference was only significant at 2.2 μm sarcomere length (Fig.4A) . Normalized tensionca alc lc ciu iu ium m m re re ela la lati ti tion ns s s w we were constructed in order to de de ete te t r r rmine myofilam am ment t Ca Ca Ca 2+- sensitivity. The e eng g gth t -depende den n nt i i inc cr re eas as ase e e in in in m m myo yo ofi fi f la la l m me men nt C C Ca 2 2 2+-se e en ns sitiv iv vi it ity y ( ( EC EC C50 50 0, i. i e e e. d d dif ffe fe fer re renc nce e e be be betw tw wee ee een n EC EC EC 50 va valu lu lues es es a at t 1. 1. .8 8 8 an and d d 2 2. 2.2μ 2μ μm) m) ) d did d d n not ot ot d d dif if iffe fer r r be be betw tw twee e en n n P P PAH AH a and nd nd c c con on ntr tr t o o ols, s, i i ind nd ndic ca ati ting ng ng p p pre rese se ser r rve e ed F Fra rank nk nkStarling mec cha ha hani ni n sm sm sm i in n n PA PA P H-H-H pa pa p ti ti tien en e ts ts ts (Fi Fi F g. g. g.4B 4B 4B). ). ) N N No o si si ign gn g if if ific ic ican an ant t ch ch chan an ange ge ges s s in in in C C Ca a a PAH compared to control is shown in Fig.5B . To determine the role of the actin-myosin interaction component in generating passive tension, RV cardiomyocytes were incubated with BDM and passive tension was measured before and after incubation: no change in passive tension was observed (Fig. 6A-C) , only a reduction in total tension (Fig. 6D) . This indicates that the increase in RV passive tension in PAH cardiomyocytes is not a consequence of residual actin-myosin interactions, but a consequence of increased RV sarcomeric stiffness derived from passive structures (titin).
Titin isoform expression and phosphorylation
To investigate the underlying molecular mechanism accounting for RV diastolic stiffness in PAH, we analyzed titin isoform composition and phosphorylation. Titin is a giant sarcomeric protein which regulates sarcomere compliance. 8 Titin consists of 2 isoforms, the stiff N2B isoform and the compliant N2BA isoform. In RV samples of PAH-patients and controls, we did not observe a difference in the ratio between N2B and N2BA isoform expression (Fig. 7A) . But, we did observe reduced titin phosphorylation in RV samples of PAH-patients (Fig. 7B) ,
indicating that the observed RV sarcomeric stiffening was associated with reduced titin phosphorylation.
Discussion
By combining in vivo measurements of RV function in PAH-patients with functional and histological analyses of RV tissue derived of PAH-patients, we were able to demonstrate that:
1. RV diastolic stiffness is increased in PAH-patients and closely associated with markers of disease severity.
2. RV hypertrophy and collagen deposition are increased in RV tissue of PAH-patients in PAH, we analyzed titin isoform composition and phosphorylation. f f Titin is a giant n nt s sar a a co co ome me meri ri ric c protein which regulates sarcomere compliance. 8 Titin consists of 2 isoforms, the stiff N2B s sof of for or orm m m an an nd d d th t the co co com mpliant N2BA isoform. In RV V V sa amples of PAH-H H pa ati ti ien en ents and controls, we did n not o observe a di di if ff f e e eren ence ce i i in n n th th he e e ra rati ti io o o be be etw w ween n n N N N2B B B a a and d N N2 N2BA BA BA i iso so ofo fo orm rm e ex xp pre re ess ss sio ion n ( (F Fi Fig. g. 7 7A A A) . ). B B But, 3. RV cardiomyocyte passive tension at different sarcomere lengths was significantly higher in PAH-cardiomyocytes than in controls; RV cardiomyocytes exhibited preserved lengthdependent activation and generated higher total tension in comparison to control RV cardiomyocytes over a broad range of calcium concentrations.
4. Titin phosphorylation was significantly reduced in RV tissue of PAH-patients in comparison to controls.
RV diastolic stiffness in PAH
Diastolic dysfunction is characterized by altered filling patterns, prolonged relaxation and intrinsic diastolic stiffness. Several epidemiological studies have demonstrated elevated RAP in PAH-patients. 24 In concordance, RV imaging studies revealed altered RV filling patterns characterized by increased atrial-induced filling ("atrial kick"). 11 In addition, prolonged RV isovolumic relaxation time has been described in PAH-patients. 11 However, previously used measurements of diastolic function are all highly load-dependent, therefore it is still unclear whether PAH-patients suffer from true RV diastolic impairment or that the observed changes in filling and relaxation are merely a reflection of increased RV afterload.
4,25
Therefore, we investigated the presence of RV diastolic impairment in PAH-patients both in vivo by single-beat PV analyses, as well as by measuring RV diastolic stiffness directly in RV cardiomyocytes. Diastolic stiffness is ideally quantified from the diastolic PV relationship constructed from multiple PV loops at different loading conditions. Due to cardio-pulmonary compromise, this procedure is highly undesirable and considered too invasive in PAH.
Therefore, we used the single-beat approach, a technique that has been used successfully in left heart failure studies. 5, 6 In our experimental PAH-model, we observed an excellent correlation ntrinsic diastolic stiffness. Several epidemiological studies have demonstrated e el le leva va v te e ed d d RA RA RAP P P i in PAH-patients. 24 In concordance, RV imaging studies revealed altered RV filling patterns ch har ar arac ac cte te teri ri rize ze zed d d by y i i in nc ncreased atrial-induced filling g ( ( ("a "a atrial kick"). between RV diastolic stiffness derived by single-and multiple-beat approach, and therefore considered the single-beat approach as an appropriate, less invasive alternative for our patients.
In addition, the finding of altered early and atrial-induced RV peak filling rate further confirmed increased RV diastolic stiffness in PAH.
RV hypercontractility
Interestingly, RV diastolic stiffness in PAH coincided with increased RV contractility (Ees) and force generating capacity of RV cardiomyocytes (active force). This finding is somewhat unexpected, since it is well known that PAH is associated with severe RV systolic dysfunction. It is also in contrast to earlier observations of diastolic left heart failure (or heart failure with preserved ejection fraction), where increased passive stiffness was accompanied by reduced active tension. 19 In a previous study in PAH-rats, we did observe an increase in both diastolic stiffness and RV contractility, consistent with our findings in cardiomyocytes of PAHpatients. 17, 18 However, the increase in RV contractility in rats did not result in an improved RVarterial coupling in rats, suggesting that the increase in RV contractility was insufficient to cope with the higher increase in RV afterload. 17 Therefore, the observed increase in force generating capacity may be a compensatory mechanism attempting to cope with the increased RV afterload. 26 This compensatory mechanism might negatively affect the normal relaxation pattern. The "hypercontractile" sarcomeres, which are evident after combining the increase in maximal force generating capacity with higher myofilament Ca 2+ -sensitivity and increased passive stiffness (Fig.5D ), may limit myocardial relaxation during the diastolic phase and contribute to impaired diastolic function in PAH-induced right heart failure.
Possible mechanisms causing RV diastolic stiffness in PAH
preserved ejection fraction), where increased passive stiffness was accompanied d by by by red ed educ uc uced ed ed active tension. 19 In a previous study in PAH-rats, we did observe an increase in both diastolic t tif if ffn fn fnes es ess s an an and d d RV RV V c c con ontractility, consistent with ou u ur r r f fi indings in card rd dio i my my yo oc ocytes of PAHpati i ien e ts. 17,18 8 H How ow we e ever er r, , th th he e e in in incr cr rea ease se se i in n RV RV co o on n ntrac c cti il lity y y in in n r ra at a s s s di did d n no not r res esul ult t in in in a an n im im impr prov ov oved ed ed R R RV V Var rte te teri ri ial al al c cou ou upl pl plin ing g g in n n r rat at ts, , s su ugge ge gest st sti i ing ng ng t tha ha at t th th the e e in ncr cr crea ea ase se e in n n RV RV RV con on ontr tr ract ct ctil il i it ity y y w wa was s s in in nsu suf ff ffic ic icie en nt nt t to o c c cop pe pe with the hig ghe he er r r in incr cr crea ea e se se se in n n RV RV RV a a aft ft fter er rlo lo l ad ad ad. . 17 17 17 T T The he h re re refo fo fore re e, , th h he e e ob ob obse se erv rv rved ed d i i in n ncr cr crea ea ease se se i in n n fo fo forc rc rce e e ge g g nerating RV diastolic stiffness was not only observed in idiopathic PAH-patients, but was also prevalent in patients with CTEPH. This indicates that RV diastolic stiffness is not specific for PAH, but could also be expected in other syndromes with increased RV pressures. Thus increased RV pressure overload could be an initial trigger for RV diastolic impairment in PAH. Nevertheless, also other factors could explain RV diastolic stiffness in PAH in vivo. We observed a 3-fold higher RV sarcomeric stiffness over the whole range of sarcomere lengths in PAH-patients compared to controls. By repeating RV sarcomeric stiffness measurements after incubation with the cross-bridge inhibitor BDM, we could rule out a contribution of remaining cross-bridge interactions on RV diastolic stiffness. A remaining factor that is likely to contribute to the high cardiomyocyte stiffness is the sarcomeric protein titin. Titin is a molecular spring that spans the half sarcomere and determines muscle stiffness in diastole. 8 Phosphorylation and isoform composition of titin determine the elasticity of the protein and thereby passive (diastolic) stiffness of the cardiomyocytes. In this study, we revealed that titin isoform composition was unaltered in PAH-cardiomyocytes, but titin phosphorylation was significantly reduced in PAH in comparison to controls. Also extracellular factors such as RV collagen deposition might contribute to diastolic impairment, though we observed only a relatively modest increase in RV collagen deposition, which is in line with previous preclinical studies. 16, 17, 27 Clinical implications RV diastolic stiffness was closely associated with markers of disease progression. This finding suggests that RV diastolic stiffness may represent a contributing factor involved in disease worsening and not a benign compensatory mechanism associated with increased afterload.
Future therapeutic strategies targeting the reduced titin phosphorylation and increased RV collagen deposition will reveal the clinical implication of increased RV diastolic stiffness.
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Limitations of the study
RV diastolic stiffness only weakly correlated with RV peak filling rate. This is comparable to earlier data in patients with heart failure with preserved ejection fraction where the direct comparison of E/A ratio (echo) with the diastolic stiffness parameter (conductance catheterization), showed a similar weak correlation. 28 A possible explanation for this finding is that E/A measurements by echo or MRI are highly sensitive to the confounding effects of increased pre-and afterload. This also indicates that other factors besides RV myocardial stiffness are associated with a reduction in E/A ratio.
The majority of RV samples used in this study were from patients with PAH secondary to congenital heart disease (CHD). RV samples of patients with idiopathic PAH are difficult to procure since these patients often undergo only lung transplantation. There may be important differences in myocardial structure and function between the right ventricle of a formerly normal adult who develops idiopathic PAH and that from CHD-patients. However, both idiopathic PAH and CHD-patients were in end-stage right heart failure at time of heart/lung transplantation (NYHA IV). More importantly, subgroup analyses revealed that the increase in active force and cardiomyocyte stiffness were comparable between RV samples of idiopathic PAH and congenital heart disease.
The sample size of this study was relatively small, which may have lead to type I errors, and therefore nominal significant p-values should be interpreted with caution. However, our main finding has been confirmed by several clinical and experimental observations. Therefore, RV diastolic stiffness in PAH is not only a statistically significant finding but also physiologically plausible. an nd d d CH CH CHD-D-pa pa pat ti tien ent ts w wer ere in in en nd nd-s -s st t tag ag age e e ri ri igh gh ght t t he he hear ar rt t t fa fa ail lu ure e e at at at t t tim im ime e e of of f h h hea ea eart rt t/ /lu un ung g tr tr t an an a sp sp spla la lant ta a ati io ion n NYHA IV). ). M M Mor or ore e e im im impo po portan an antl tl tly, , , s s sub ub ubgr g g ou ou oup p p an an anal al alys ys yses es es r r rev ev e e e eal al a ed ed ed t tha ha hat t t th the e e in in incr cr crea ea ease se s i i in n n ac ac acti ti tive ve v force and
Conclusion
We demonstrated that patients with PAH have increased RV diastolic stiffness. Furthermore, we observed significant correlations between increased diastolic stiffness and disease severity. We revealed that alterations in the extracellular matrix and cardiomyocyte sarcomeres are both important contributors to increased RV diastolic stiffness in PAH-patients and may represent future treatment targets.
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RV sample Diagnosis NYHA Class  Gender  Age  1  Idiopathic PAH  IV  Female  38  2  Idiopathic PAH  IV  Female  44  3  Idiopathic PAH  IV  Female  51  4  PAH-Eisenmenger  IV  Female  46  5  PAH-Eisenmenger  IV  Female  14  6  PAH-Eisenmenger  IV  Female  20  7  PAH-Eisenmenger  IV  Female  31  8  PAH-Eisenmenger  IV  Female  21  9  PAH-Eisenmenger  IV  Male  46  10  PAH-Eisenmenger  IV  Female  50  11  PAH-Eisenmenger  IV  Female  41  12  Donor  Female  41  13  Donor  Female  23  14  Donor  Female  19  15  Donor  Female  53  16  Donor  Male  65  17  Donor  Female  49  18  Donor  Male  45  19  Donor  Female  38  20  Donor  Male  37 PAH: pulmonary arterial hypertension. NYHA: New York Heart Association Table 4 . PA PA AH-H-H-pa pa pati tien en nts ts ts i in n co o omp mp par r ris ison on t to o co co cont nt ntro rols ls l . Th Th The e ty ty typi pi ica ca al l e ex exam am amp p ple e e of of of the he he g ge e el e e ele lec ct ctro ro oph ph phor or orese e e il l llu lust st tra a ate tes educed titin n ph ph phos os osph ph phor or ryl yl y at tio io ion n n in n n RV RV RV t tis s ssu su sue e e of of of P P PAH AH AH-p -p pat a ie ie ent nt nts. s. s. Da Da Data ta t p p pre re rese se sent nt nted ed ed a a as s s me me mean an an ± SEM, Pressure--volume loops were recorded at rest and after preload reduction secondary to vena cava gradual occlusion (VCO). Analysis was made off line using custom--made algorithms (programmed in MATLAB 2007b, The MathWorks, Natick MA).
RV sample
Doppler ultrasound derived stroke volume was used to convert catheter volume units in milliliters. One catheterization unit was calculated to its corresponding volume (ml) by dividing the ultrasound obtained stroke volume (ml) by the catheterization stroke volume (units).
Catheterization stroke volume was previously obtained from subtracting the end systolic volume (units) from the end diastolic volume (units). Due to procedure limitations to record absolute RV volumes (End Systolic Volume and End Diastolic Volume), only changes in volume could be measured, all end diastolic volumes were normalized at 1.5ml and end systolic volumes were calculated by subtracting the stroke volume (ml) from the reference point (1.5ml).
To quantify RV diastolic stiffness, multiple pressure--volume loops were recorded with the pressure--volume catheter placed in the right ventricle, both at steady state and during vena cava occlusion. The diastolic pressure--volume relation was then constructed using an exponential fit (Equation 1: P=α (e Vβ --1) ) through the decreasing pressure--volume points (after vena cava occlusion) and the diastolic stiffness factor βmultiple was calculated. The same equation was used to calculate RV diastolic stiffness βsingle from a single beat pressure--volume loop (recorded before vena cava occlusion was started, at steady--state). For this exponential fit only 3 points were used: 1) 0pressure,0volume point, 2) begin diastolic point and 3) end diastolic point.
The classical pressure--volume relation implies the construction of an exponential pressure--volume curve through decreasing pressure--volume points. Furthermore, the pressure--volume relation is considered to intersect the volume axes at pressure=0mmHg and a certain intercept volume (Vd). To calculate βsingle, Vd was set to 0. Although physiologically inexact, we considered the 0pressure--0volume point as a satisfactory substitute for the intercept since: 1. 0volume is always lower or equal to Vd quantify RV diastolic stiffness). See also Fig.S1 Supplemental RESULTS
RV diastolic stiffness
RV Diastolic stiffness obtained with the classical method using multiple pressure--volume loops (βmultiple) was compared to diastolic stiffness obtained from a single beat steady--state loop (βsingle). S4,5 Since no significant difference was found between the methods (Fig.  S2) , we further used the single beat approach for the clinical setting, where vena cava occlusion and multiple pressure--volume loops recording are contraindicated.
Right ventricular cardiomyocyte force measurements
To investigate whether resting sarcomere length was different between PAH and control tissue samples, we randomly selected 10 isolated RV cardiomyocytes for each control and PAH tissue sample. S6 Resting sarcomere length was optically determined in at lease two distinct areas of the cell and the average cellular sarcomere length was calculated. No significant difference in resting sarcomere length was found between control and PAH cardiomyocytes (Fig. S3) To investigate whether our findings of increased RV active force and cardiomyocyte stiffness differ between RV samples obtained from patients with idiopathic PAH or PAH secondary to congenital heart disease, we performed a subgroup analyses. As can be observed in Fig.  S4 , the increase in RV active force and RV cardiomyocyte stiffness was comparable among the groups.
Supplemental FIGURE LEGENDS
Figure S1 C. Method correlation between diastolic stiffness βmultiple and βsingle in control rats and PAH rats.
Figure S3
Right ventricular resting sarcomere length determined in control and PAH isolated skinned cardiomyocytes. p=0.56
Figure S4
Measures of right ventricular active force and stiffness do not differ between right ventricular cardiomyocytes obtained from patients with idiopathic pulmonary arterial hypertension or congenital heart disease.
Data presented as mean ± SEM. iPAH, idiopathic pulmonary arterial hypertension; CHD, congenital heart disease. 
